Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07356050

Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease

Sponsor: Children's Hospital Medical Center, Cincinnati

View on ClinicalTrials.gov

Summary

The goal of this study is to learn if infants with sickle cell disease (SCD) develop adequate protection after measles vaccines. (not looking at any prolonged duration)

Official title: Verifying Antibodies After Live Immunization Delivery (VALID): a Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease

Key Details

Gender

All

Age Range

6 Months - 6 Years

Study Type

OBSERVATIONAL

Enrollment

130

Start Date

2025-03-13

Completion Date

2028-12-31

Last Updated

2026-01-21

Healthy Volunteers

No

Locations (3)

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States

Korle Bu Teaching Hospital

Accra, Ghana, Ghana

Bugando Medical Centre

Mwanza, Tanzania